Finance

Beta
Lists
B8FK:FRA
Biofrontera AG
€2.21
-0.90%
(-0.020) 1D
Jun 24, 8:01:12 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for B8FK...
Open
€2.21
High
€2.21
Low
€2.21
Mkt. cap
13.67M
Avg. vol.
271.00
Volume
0.00
52-wk high
€2.85
52-wk low
€2.01
EPS
-€0.41
No. of employees
69
Open
€2.21
High
€2.21
Low
€2.21
Mkt. cap
13.67M
Avg. vol.
271.00
Volume
0.00
52-wk high
€2.85
52-wk low
€2.01
EPS
-€0.41
No. of employees
69
News stories
From sources across the web
About Biofrontera AG
CEO-
Employees69
Founded1997
Headquarters-
SectorPharmaceutical industry
Websitebiofrontera.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.27M
3.55M
-
3.71M
Cost of goods sold
592.00K
1.15M
-
709.00K
Cost of revenue
592.00K
1.15M
-
709.00K
Research and development expenses
554.00K
1.20M
-
539.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.34M
2.20M
-
2.46M
Operating expense
2.90M
3.40M
-
3.00M
Total operating expenses
3.49M
4.56M
-
3.70M
Operating income
-214.00K
-1.00M
-
9.00K
Other non operating income
-11.00K
540.00K
-
38.00K
EBT including unusual items
-226.00K
-369.00K
-
41.00K
EBT excluding unusual items
-226.00K
-369.00K
-
41.00K
Income tax expense
-
1.00K
-
-
Effective tax rate
-
-0.27%
-
-
Other operating expenses
-
-
-
-
Net income
678.00K
-370.00K
-
2.20M
Net profit margin
20.71%
-10.41%
-
59.24%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.00K
-1.00K
-
-6.00K
Net interest expenses
-1.00K
-1.00K
-
-6.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-153.50K
-940.50K
-
54.75K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer